Early Drug Development Group

Our preclinical and clinical operation structures rely on an interdisciplinary group of medical oncologists, pharmacologists and molecular biology experts with extensive experience in preclinical studies and clinical trials. We are capable of offering professional services covering all stages of your R&D program, to establish an attractive route to the clinic in a fast, efficient and cost effective manner.
Learn More
Optimize, Innovate, Collaborate
SERVICES
We support medtech and biotech start-ups, pharmaceutical companies, investment fund groups and academic organizations in oncology to foster their R&D programs in a time- and cost-effective manner.
Management and execution of an efficient R&D program in oncology.
icono4
icono2
Broad capabilities in preclinical, pharmacokinetics and radiopharmacology studies to guide clinical development.
Assistance on preclinical, pharmacological and CMC approaches, regulatory strategies and Phase I clinical trials in oncology.
icono1
icono3
Advice on the reliability and feasibility of reported preclinical and clinical data.

OUR STRENGTHS

Our strength relies on an interdisciplinary team of medical oncologists, pharmacologists and molecular biology experts with unparalleled experience in non-clinical and clinical trial studies.

WHY US?

We are interdisciplinary research group of medical oncologists, pharmacologists and molecular biology experts. We have performed several drug development programs with more than 20 companies -ranging from small biotech to the largest pharma companies- for the evaluation of over 20 different leads (at least 8 first-in-man) in oncology, covering both small molecules and monoclonal antibodies.   Over the last years, we have established a long-standing network of trusted partner companies and world-class investigators experienced in early drug development and cancer research in oncology and immunology. This enable us to offer an attractive route to the clinic optimized in terms of time and costs.

Contact Info

  •   1 Place Paul Verlaine 92100. France
  •   e2dg.contact@e2dg.com.
  •   +33 1 83 75 86 32.
NEWS

5-7 November, 2018

24th ANNUAL INTERNATIONAL PARTNERING CONFERENCE BIO-EUROPE, Copenhagen, Denmark

Please contact us to organize a meeting with E2DG team during BIO-EUROPE 2018 Meeting. To get more information on this conference follow this link.

13-16 November 2018

30th EORTC-NCI-AACR Symposium. Dublin, Ireland

Please contact us to organize a meeting with E2DG team during the 30th EORTC-NCI-AACR meeting. To get more information on this conference follow this link.

24-25 October 2018

Galien Medstart'UP Meeting, New York, USA

E2DG selected to be part of the French delegation during the Galien Medstartup 2018 meeting, an initiative between The Galien Foundation and Business France to encourage and reward international partnerships between French and North American innovators in the Life Sciences Industry. To get more information on this meeting follow this link.

1st October 2018

COST Action "Cancer nanomedicine - from the bench to the bedside".

We are pleased to announced that E2DG is part of the Management Committee of the COST Action CA17140 "Cancer nanomedicine - from the bench to the bedside". To get more information on this action follow this link.

More News & Events

 

WANT TO LEARN MORE?

We look forward to learning about your specific needs, please contact us.